Abeona Therapeutics Inc

Ticker ABEO

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in New York City, New York

Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse for the treatment of rectal mucositis…More

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (152)

Abeona Therapeutics Inc reports have an aggregate usefulness score of 4.8 based on 152 reviews.

Abeona Therapeutics Inc

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Abeona Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.